As of Feb 05
| +0.01 / +0.50%|
The 4 analysts offering 12-month price forecasts for Opexa Therapeutics Inc have a median target of 7.75, with a high estimate of 18.00 and a low estimate of 6.00. The median estimate represents a +285.57% increase from the last price of 2.01.
The current consensus among 4 polled investment analysts is to Buy stock in Opexa Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.